Under the agreement, Technology Development Board and Bharat Biotech have pledged the support of Rs.200 crore each to create a continuous corpus of Rs.400 crores for the project
The survey indicates that 30% of people are still feeling depressed or hopeless on a few days as against GOQii’s last year survey on mental Health where 43% of Indians were depressed
Phase 2a clinical proof-of-concept biomarker study for PXL065 in ALD now anticipated to start midyear
The objective behind introducing this extraordinary digital campaign is to spread awareness among Gen X and Z for the need of breast self-examination
The company plans to expand their capacity to meet the needs of pharma and biotech industries
Healtherbs helps in restoring the desired energy levels for daily activity and immunity
Arrowhead to receive US $ 120 million upfront payment for Phase 1/2 program for NASH and is eligible to receive potential milestone payments and royalties on commercial sales
Dicerna develops RNAi-based therapies to selectively silence genes that cause or contribute to disease
Early detection of breast cancer increases survival rate by 95 per cent
Diabetes has the highest prevalence and comorbidities among all NCD’s in India and it is mostly found among people in the south and east India
Subscribe To Our Newsletter & Stay Updated
